Literature DB >> 7865489

Interphase cytogenetics of lung tumors using in situ hybridization: numerical aberrations.

S Y Kim1, K J Lee, S C Hong, P S Han, J J Lee, H J Cho, A K Kim, J O Kim, M S Lee.   

Abstract

OBJECTIVES: Since conventional cytogenetic analysis for bronchogenic carcinogenesis is limited by the difficulty to get enough number of high quality metaphase spreads, the development of new method to overcome above problems is strongly needed. Therefore, the introduction of non-radioactive in situ hybridization (ISH) with pericentromeric chromosome probes gave us the way to investigate the genetic events during carcinogenic process. We applied this method on lung cancer tissue to validate the possibility of this method for general usage and to analyze numerical chromosome aberration status and their clinical correlations.
METHODS: A set of satellite DNA probes specific for chromosome 3, 7, 9, 11, and 17 was hybridized directly to paraffin-embedded tissue section of 30 non-small cell lung cancers. Mean chromosome index of each chromosome and frequency of polysomy for each chromosome were calculated.
RESULTS: Mean chromosome indices for chromosome 3, 7, 9, 11, and 17 were 1.10, 1.13, 1.17, 1.12, and 1.17, respectively. Polysomy for a set of chromosomes was detected in all 30 cases except 4 cases which showed hypoploidy only for chromosome 3 or 7 in 2 cases and diploidy only for chromosome 3 or 11 in 2 cases. Among the set of chromosomes, mean chromosome index and polysomy frequency for chromosome 9 & 17 were significantly higher than that for others. Mean chromosome index or polysomy pattern for each chromosome was not much different among cell types or clinical stages.
CONCLUSIONS: Our results show that chromosome ISH can be used to screen for numerical chromosome aberrations on paraffin tissue sections and further studies for ISH analysis with different probes on same tumor area or double-target ISH in large scale are needed to confirm above results and to elucidate the specific meanings.

Entities:  

Mesh:

Year:  1994        PMID: 7865489      PMCID: PMC4532067          DOI: 10.3904/kjim.1994.9.2.55

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  28 in total

1.  Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Authors:  J Whang-Peng; T Knutsen; A Gazdar; S M Steinberg; H Oie; I Linnoila; J Mulshine; M Nau; J D Minna
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

2.  Multiple fluorescence in situ hybridization.

Authors:  P M Nederlof; S van der Flier; J Wiegant; A K Raap; H J Tanke; J S Ploem; M van der Ploeg
Journal:  Cytometry       Date:  1990

3.  Rapid interphase and metaphase assessment of specific chromosomal changes in neuroectodermal tumor cells by in situ hybridization with chemically modified DNA probes.

Authors:  T Cremer; D Tesin; A H Hopman; L Manuelidis
Journal:  Exp Cell Res       Date:  1988-06       Impact factor: 3.905

Review 4.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

5.  Cytogenetic study of five cases of lung adenosquamous carcinomas.

Authors:  A Flüry-Hérard; E Viegas-Péquignot; H De Cremoux; C Chlecq; J Bignon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1992-03

6.  Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes.

Authors:  P J Poddighe; O Moesker; D Smeets; B H Awwad; F C Ramaekers; A H Hopman
Journal:  Cancer Res       Date:  1991-04-01       Impact factor: 12.701

7.  Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities.

Authors:  R Lukeis; L Irving; M Garson; S Hasthorpe
Journal:  Genes Chromosomes Cancer       Date:  1990-07       Impact factor: 5.006

8.  Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridization.

Authors:  P M Nederlof; S van der Flier; A K Raap; H J Tanke; M van der Ploeg; F Kornips; J P Geraedts
Journal:  Cancer Genet Cytogenet       Date:  1989-10-01

9.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 10.  The chromosomal analysis of human solid tumors. A triple challenge.

Authors:  J R Teyssier
Journal:  Cancer Genet Cytogenet       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.